Ameritas Investment Partners’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Ameritas Investment Partners’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,080	Closed	-$129K	–	3100
2023 Q4	$129K	Buy	+2,080	New	+$51.7K	﹤0.01%	1566

Ameritas Investment Partners's RYZB Position: Q1 2024 in Review

Ameritas Investment Partners sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 2,080 shares — an estimated $129K sold.

Ameritas Investment Partners first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $129K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Ameritas Investment Partners reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Ameritas Investment Partners sold 2,080 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $129K.
Ameritas Investment Partners first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Ameritas Investment Partners's RayzeBio, Inc. Common Stock position peaked at $129K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Ameritas Investment Partners's 13F filing for Q1 2024, filed 13 May 2024.